Drug Manufacturers - Specialty & Generic Companies By Enterprise Value
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Valuation
| Current Valuation | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | LNTH | Lantheus Holdings | (0.06) | 3.68 | (0.22) | ||
| 2 | BIOA | BioAge Labs, | 0.05 | 5.51 | 0.25 | ||
| 3 | YCBD-PA | cbdMD Inc | 0.09 | 4.75 | 0.43 | ||
| 4 | RMTI | Rockwell Medical | (0.03) | 7.03 | (0.20) | ||
| 5 | GELS | Gelteq Limited Ordinary | (0.20) | 9.40 | (1.87) | ||
| 6 | NSRS | North Springs Resources | 0.00 | 0.00 | 0.00 | ||
| 7 | KALY | Kali Inc | 0.00 | 0.00 | 0.00 | ||
| 8 | KGET | Kleangas Energy Tech | 0.00 | 0.00 | 0.00 | ||
| 9 | SXTC | China SXT Pharmaceuticals | (0.16) | 6.53 | (1.02) |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.